[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100642613":3},{"organization":4,"armGroups":7,"interventions":10,"overallOfficials":15,"centralContacts":19,"locations":25,"responsibleParty":130,"collaborators":10,"id":132,"slug":133,"hasResults":134,"nctId":135,"briefTitle":136,"officialTitle":137,"acronym":138,"eligibilityCriteria":139,"healthyVolunteers":134,"sex":140,"minAge":10,"maxAge":10,"enrollmentInfo":141,"targetDuration":10,"studyType":144,"phases":10,"briefSummary":145,"conditions":146,"keywords":154,"overallStatus":28,"whyStopped":10,"lastUpdateSubmitDate":160,"lastUpdatePostDateStruct":161,"startDateStruct":164,"completionDateStruct":166,"leadSponsor":168,"locationsCount":169},{"fullName":5,"class":6},"BillionToOne Inc.","INDUSTRY",[8,12],{"label":9,"type":10,"description":11,"interventionNames":10},"High Risk",null,"Pregnant individuals between 10 and 20 weeks of gestation with singleton pregnancies and who have a clinical indication for CFC testing, such as high-risk cfDNA results for common aneuploidies, copy number variants including 22q11.2, or sex chromosome aneuploidies",{"label":13,"type":10,"description":14,"interventionNames":10},"General Risk","Pregnant individuals between 10 and 20 weeks of gestation with singleton pregnancies (excluding gestational surrogates) who do not have a clinical indication for CFC and are undergoing prenatal diagnostic testing",[16],{"name":17,"affiliation":5,"role":18},"Julia Wynn, MS, MS, CGC","PRINCIPAL_INVESTIGATOR",[20],{"name":21,"role":22,"phone":23,"phoneExt":10,"email":24},"Shannon O'Rourke Senior Research Manager, MS, CGC","CONTACT","650-460-2551","unityregistry@billiontoone.com",[26,47,63,80,97,114],{"facility":27,"status":28,"city":29,"state":30,"zip":31,"country":32,"countryCode":33,"cosmosGeoPoint":34,"geoPoint":39,"contacts":40},"Valley Perinatal Services","RECRUITING","Phoenix","Arizona","85004","United States","US",{"type":35,"coordinates":36},"Point",[37,38],-112.07404,33.44838,{"lat":38,"lon":37},[41,45],{"name":42,"role":22,"phone":43,"phoneExt":10,"email":44},"Research Department","480-756-6000","research@valleyperinatal.com",{"name":46,"role":18,"phone":10,"phoneExt":10,"email":10},"Nayo Williams, MD",{"facility":48,"status":28,"city":49,"state":50,"zip":51,"country":32,"countryCode":33,"cosmosGeoPoint":52,"geoPoint":56,"contacts":57},"San Gabriel Valley Perinatal Medical Group","West Covina","California","91710",{"type":35,"coordinates":53},[54,55],-117.93895,34.06862,{"lat":55,"lon":54},[58,62],{"name":59,"role":22,"phone":60,"phoneExt":10,"email":61},"Richard Burwick, MD","(626) 337-4425","dr.burwick@sgvpmg.com",{"name":59,"role":18,"phone":10,"phoneExt":10,"email":10},{"facility":64,"status":28,"city":65,"state":66,"zip":67,"country":32,"countryCode":33,"cosmosGeoPoint":68,"geoPoint":72,"contacts":73},"Sarasota Memorial Health Care System","Sarasota","Florida","34239",{"type":35,"coordinates":69},[70,71],-82.53065,27.33643,{"lat":71,"lon":70},[74,78],{"name":75,"role":22,"phone":76,"phoneExt":10,"email":77},"Scarleth Andino-Funez, BSN, RN","941-917-2627","Scarleth-AndinoFunez@smh.com",{"name":79,"role":18,"phone":10,"phoneExt":10,"email":10},"Larry C Matsumoto, MD",{"facility":81,"status":28,"city":82,"state":83,"zip":84,"country":32,"countryCode":33,"cosmosGeoPoint":85,"geoPoint":89,"contacts":90},"Pediatrix Medical Group of Georgia","Atlanta","Georgia","30342",{"type":35,"coordinates":86},[87,88],-84.38798,33.749,{"lat":88,"lon":87},[91,95],{"name":92,"role":22,"phone":93,"phoneExt":10,"email":94},"Deena Yowler, NP, CNM","404-847-1592","deena.yowler@pediatrix.com",{"name":96,"role":18,"phone":10,"phoneExt":10,"email":10},"Gretchen Koontz, MD",{"facility":98,"status":28,"city":99,"state":100,"zip":101,"country":32,"countryCode":33,"cosmosGeoPoint":102,"geoPoint":106,"contacts":107},"Woman's Hospital","Baton Rouge","Louisiana","70817",{"type":35,"coordinates":103},[104,105],-91.18747,30.44332,{"lat":105,"lon":104},[108,112],{"name":109,"role":22,"phone":110,"phoneExt":10,"email":111},"Bri Jones, MPH","225-927-1300","Briasha.Jones@womans.org",{"name":113,"role":18,"phone":10,"phoneExt":10,"email":10},"Elizabeth Sutton, PhD",{"facility":115,"status":28,"city":116,"state":117,"zip":118,"country":32,"countryCode":33,"cosmosGeoPoint":119,"geoPoint":123,"contacts":124},"Pediatrix Medical Group","Houston","Texas","773339",{"type":35,"coordinates":120},[121,122],-95.36327,29.76328,{"lat":122,"lon":121},[125,129],{"name":126,"role":22,"phone":127,"phoneExt":10,"email":128},"Olaide Ashimi Balogun, MD","346-616-2777","olaide.ashimibalogun@pediatrix.com",{"name":126,"role":22,"phone":10,"phoneExt":10,"email":10},{"type":131,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100642613","the-advance-assay-development-and-validation-for-pre-natal-and-obstetric-conditions-study-is-the-largest-us-based-prospective-study-demonstrating-a-circulating-fetal-cell-cfc-based-approach-to-non-invasive-fetal-risk-assessment-100642613",false,"NCT07643896","The ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) Study is the Largest U.S.-Based Prospective Study Demonstrating a Circulating Fetal Cell (CFC) Based Approach to Non-invasive Fetal Risk Assessment","ADVANCE Study: Assay Development and Validation for Pre-Natal and Obstetric Conditions","ADVANCE","Inclusion Criteria:\n\n* pregnant individuals between 10 and 20 weeks of gestation\n* singleton gestation\n\nExclusion Criteria:\n\n\\- active cancer","FEMALE",{"count":142,"type":143},1000,"ESTIMATED","OBSERVATIONAL","The goal of the ADVANCE (Assay Development and Validation for Pre-Natal and Obstetric Conditions) study is to compare the concordance of results of a novel non-invasive circulating fetal cell (CFC) assay to the results of prenatal invasive diagnostic testing or postnatal genetic and clinical diagnosis of the resulting neonate. This is a prospective study of pregnant individuals.",[147,148,149,150,151,152,153],"Pregnant Individuals","Aneuploidy","Down Syndrome (Trisomy 21)","22q11.2 Deletion Syndrome","Trisomy 13","Trisomy 18","Sex Chromosome Abnormalities",[155,156,157,158,159],"pregnant","aneuploidy","NIPT","NIPS","circulating fetal cell","2026-06-10",{"date":162,"type":163},"2026-06-12","ACTUAL",{"date":165,"type":163},"2026-01-10",{"date":167,"type":143},"2028-06",{"name":5,"class":6},6]